<?xml version="1.0" encoding="UTF-8"?>
<ref id="B34-ijms-19-01312">
 <label>34.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Allen</surname>
    <given-names>S.J.</given-names>
   </name>
   <name>
    <surname>Watson</surname>
    <given-names>J.J.</given-names>
   </name>
   <name>
    <surname>Shoemark</surname>
    <given-names>D.K.</given-names>
   </name>
   <name>
    <surname>Barua</surname>
    <given-names>N.U.</given-names>
   </name>
   <name>
    <surname>Patel</surname>
    <given-names>N.K.</given-names>
   </name>
  </person-group>
  <article-title>GDNF, NGF and BDNF as therapeutic options for neurodegeneration</article-title>
  <source>Pharmacol. Ther.</source>
  <year>2013</year>
  <volume>138</volume>
  <fpage>155</fpage>
  <lpage>175</lpage>
  <pub-id pub-id-type="doi">10.1016/j.pharmthera.2013.01.004</pub-id>
  <?supplied-pmid 23348013?>
  <pub-id pub-id-type="pmid">23348013</pub-id>
 </element-citation>
</ref>
